Triheptanoin
STUDY23040121
Phase 2 small_molecule active
Quick answer
Triheptanoin for Medium-chain Acyl-CoA Dehydrogenase Deficiency is a Phase 2 program (small_molecule) at Ultragenyx Pharmaceutical with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx Pharmaceutical
- Indication
- Medium-chain Acyl-CoA Dehydrogenase Deficiency
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active